Santhera Pharmaceuticals Holding AG (SWX:SANN)
18.48
-0.06 (-0.32%)
Apr 29, 2026, 12:42 PM CET
SWX:SANN Balance Sheet
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 22.44 | 40.93 | 30.37 | 1.35 | 21.21 | Upgrade
|
| Cash & Short-Term Investments | 22.44 | 40.93 | 30.37 | 1.35 | 21.21 | Upgrade
|
| Cash Growth | -45.17% | 34.76% | 2144.64% | -93.62% | 70.88% | Upgrade
|
| Accounts Receivable | 26.04 | 9.06 | 0.44 | 0.44 | 0.96 | Upgrade
|
| Other Receivables | - | 4.83 | 1.72 | 0.65 | 0.97 | Upgrade
|
| Receivables | 26.04 | 13.89 | 2.16 | 1.09 | 1.94 | Upgrade
|
| Inventory | 24.87 | 17.53 | 1.81 | 0.11 | 0.43 | Upgrade
|
| Prepaid Expenses | 0.58 | 0.37 | 0.32 | 0.51 | 1.07 | Upgrade
|
| Other Current Assets | 6.32 | 3.1 | - | - | - | Upgrade
|
| Total Current Assets | 80.24 | 75.81 | 34.66 | 3.07 | 24.64 | Upgrade
|
| Property, Plant & Equipment | 2.01 | 2.57 | 0.58 | 1.01 | 1.32 | Upgrade
|
| Long-Term Investments | 0.32 | 0.25 | 0.42 | 0.44 | 0.47 | Upgrade
|
| Other Intangible Assets | 63.94 | 68.95 | 73.97 | 59.21 | 64.6 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | 0 | 0.09 | Upgrade
|
| Other Long-Term Assets | 1.58 | 4.91 | - | - | - | Upgrade
|
| Total Assets | 148.09 | 152.49 | 109.63 | 63.73 | 91.12 | Upgrade
|
| Accounts Payable | 18.01 | 5.75 | 3.56 | 3.9 | 2.41 | Upgrade
|
| Accrued Expenses | 19.4 | 19.35 | 9.57 | 10.85 | 9.71 | Upgrade
|
| Short-Term Debt | - | - | - | 22.13 | 1.49 | Upgrade
|
| Current Portion of Long-Term Debt | 14.26 | 6.4 | 20.94 | - | 13.88 | Upgrade
|
| Current Portion of Leases | 0.59 | 0.55 | 0.57 | 0.62 | 0.61 | Upgrade
|
| Current Income Taxes Payable | 0.89 | 0.14 | 0.18 | 0.55 | 0.27 | Upgrade
|
| Current Unearned Revenue | 0.14 | 0.06 | - | - | - | Upgrade
|
| Other Current Liabilities | 8.88 | 13.9 | 10.97 | 11.36 | 4.42 | Upgrade
|
| Total Current Liabilities | 62.17 | 46.14 | 45.79 | 49.41 | 32.78 | Upgrade
|
| Long-Term Debt | 32.73 | 31.73 | - | 21.08 | 25.8 | Upgrade
|
| Long-Term Leases | 1.37 | 1.94 | 0.04 | 0.61 | 1.2 | Upgrade
|
| Long-Term Unearned Revenue | 3.16 | 1.93 | - | - | - | Upgrade
|
| Pension & Post-Retirement Benefits | 6.52 | 7.67 | 3.86 | 1.84 | 4.79 | Upgrade
|
| Other Long-Term Liabilities | 53.96 | 35.38 | - | 34.47 | 25.21 | Upgrade
|
| Total Liabilities | 159.9 | 124.79 | 49.69 | 107.41 | 89.79 | Upgrade
|
| Common Stock | 1.4 | 1.34 | 1.26 | 0.75 | 54.61 | Upgrade
|
| Retained Earnings | -663.93 | -614.69 | -572.72 | -627.5 | -556.43 | Upgrade
|
| Treasury Stock | -0.06 | -0.07 | -0.13 | -0.09 | -5.02 | Upgrade
|
| Comprehensive Income & Other | 650.77 | 641.11 | 631.53 | 583.16 | 508.17 | Upgrade
|
| Shareholders' Equity | -11.82 | 27.7 | 59.94 | -43.69 | 1.33 | Upgrade
|
| Total Liabilities & Equity | 148.09 | 152.49 | 109.63 | 63.73 | 91.12 | Upgrade
|
| Total Debt | 48.95 | 40.62 | 21.55 | 44.44 | 42.98 | Upgrade
|
| Net Cash (Debt) | -26.51 | 0.31 | 8.82 | -43.08 | -21.77 | Upgrade
|
| Net Cash Growth | - | -96.54% | - | - | - | Upgrade
|
| Net Cash Per Share | -2.04 | 0.03 | 0.81 | -7.07 | -6.37 | Upgrade
|
| Filing Date Shares Outstanding | 13.27 | 12.79 | 11.32 | 6.59 | 4.96 | Upgrade
|
| Total Common Shares Outstanding | 13.27 | 12.79 | 11.32 | 6.59 | 4.96 | Upgrade
|
| Working Capital | 18.07 | 29.67 | -11.14 | -46.35 | -8.14 | Upgrade
|
| Book Value Per Share | -0.89 | 2.17 | 5.30 | -6.63 | 0.27 | Upgrade
|
| Tangible Book Value | -75.75 | -41.25 | -14.02 | -102.89 | -63.27 | Upgrade
|
| Tangible Book Value Per Share | -5.71 | -3.22 | -1.24 | -15.62 | -12.76 | Upgrade
|
| Machinery | - | 1.46 | 1.35 | 1.46 | 1.82 | Upgrade
|
| Leasehold Improvements | - | 1.48 | 1.48 | 1.5 | 1.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.